(Q34985302)

5 August 2017

A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer (English)

1 reference

5 August 2017

1 reference

1 reference

8

Perry W Grigsby

1 reference

5 August 2017

Xiaoxia Hu

1

1 reference

5 August 2017

Dusten M Macdonald

2

1 reference

5 August 2017

Phyllis C Huettner

3

1 reference

5 August 2017

Zhihui Feng

4

1 reference

5 August 2017

Issam M El Naqa

5

1 reference

5 August 2017

Julie K Schwarz

6

1 reference

5 August 2017

David G Mutch

7

1 reference

5 August 2017

Simon N Powell

9

1 reference

5 August 2017

Xiaowei Wang

10

1 reference

5 August 2017

language of work or name

English

0 references

publication date

5 June 2009

1 reference

5 August 2017

1 reference

5 August 2017

114

1 reference

5 August 2017

457-464

1 reference

5 August 2017

3

1 reference

5 August 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

Individualized care for patients with cancer - a work in progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

Gene expression signature with independent prognostic significance in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

The functions of animal microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

How microRNAs control cell division, differentiation and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

miRNA profiling for diagnosis and prognosis of human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

MicroRNA signatures in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

MicroRNA expression and identification of putative miRNA targets in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

MicroRNA expression profiles in serous ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

A PCR-based platform for microRNA expression profiling studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

A PCR primer bank for quantitative gene expression analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

Identifying differentially expressed genes using false discovery rate controlling procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

Prediction of both conserved and nonconserved microRNA targets in animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

miRDB: a microRNA target prediction and functional annotation database with a wiki interface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

The p21-activated kinase PAK is negatively regulated by POPX1 and POPX2, a pair of serine/threonine phosphatases of the PP2C family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

Exocyst is involved in cystogenesis and tubulogenesis and acts by modulating synthesis and delivery of basolateral plasma membrane and secretory proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

Androgen dependent regulation of protein kinase A subunits in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

EphA2 expression is associated with aggressive features in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

EphA2 overexpression promotes ovarian cancer growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

EphA2 overexpression is associated with angiogenesis in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.05.022

10.1016/J.YGYNO.2009.05.022

7 January 2021

Identifiers

DOI

1 reference

5 August 2017

1 reference